A comprehensive view of Pediatrics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: Sanofi and Regeneron’s additional label expansion for Dupixent reinforces its dominance in atopic dermatitis market; Dupixent expected to reach sales of US$5.3B in US by 2030, showcasing its blockbuster potential in a lucrative market
Published: July 05, 2022 by GlobalData Plc
Ballad Health starts first phase of construction on US$30M J.D. Nicewonder Family Perinatal and Pediatric Institute at Niswonger Children's Hospital in Johnson City, Tennessee; phase two to add two-floor addition to house neonatal intensive care unit
Published: June 21, 2022 by Targeted News Service (Press Releases)
Annual number of unintentional pediatric ingestions of melatonin increased 530% from 2012 to 2021 to total of 260,436 ingestions; hospitalizations, serious outcomes in kids aged 5 or younger increased during study period, with two deaths: study
Published: June 13, 2022 by The Breeze (James Madison University)
Regeneron and Sanofi’s injectable anti-inflammatory drug Dupixent dupilumab cleared in US to treat children six months to five years old with atopic dermatitis or eczema; drug had previously been approved for children aged six years and older
Published: June 10, 2022 by SeeNews Pharmaceuticals
Masimo PVi may give ER doctors noninvasive tool to determine severity of asthma attacks in pediatric patients; acute asthma attacks are a common cause of admission to emergency departments among children: study
Published: May 26, 2022 by Business Wire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count